mRNA |
RAF265 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.006 |
mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.006 |
mRNA |
Methotrexate |
FIMM |
pan-cancer |
AAC |
-0.38 |
0.007 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.007 |
mRNA |
Rapamycin |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.007 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.007 |
mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.5 |
0.008 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.008 |
mRNA |
AMG-706 |
FIMM |
pan-cancer |
AAC |
0.46 |
0.008 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.008 |